These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11291518)

  • 21. Activity of intravenous immune globulins against Klebsiella.
    Cryz SJ; Cross AS; Fürer E; Chariatte N; Sadoff JC; Germanier R
    J Lab Clin Med; 1986 Sep; 108(3):182-9. PubMed ID: 3746094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulin: a review.
    Eibl MM; Wedgwood RJ
    Immunodefic Rev; 1989; 1 Suppl():1-42. PubMed ID: 2698646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.
    Goudsmit J; Marissen WE; Weldon WC; Niezgoda M; Hanlon CA; Rice AB; Kruif Jd; Dietzschold B; Bakker AB; Rupprecht CE
    J Infect Dis; 2006 Mar; 193(6):796-801. PubMed ID: 16479514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of passive rabies immunotherapy: from the past to the future].
    Bourhy H; Dacheux L; Ribadeau-Dumas F
    Biol Aujourdhui; 2010; 204(1):71-80. PubMed ID: 20950578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immune globulin therapy of extensive Trichophyton rubrum infection.
    SHECTOR WE; MORGAN RF; BLUM W
    AMA Arch Derm; 1957 Aug; 76(2):252-3. PubMed ID: 13443522
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab. (American Academy of Pediatrics).
    Canfield SD; Simoes EA
    Pediatr Ann; 1999 Aug; 28(8):507-14. PubMed ID: 10483596
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms and uses of intravenous immune globulin in primary ond secondary immune deficiency disorders. Naples, Florida, October 13-14, 1988.
    J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 2):565-648. PubMed ID: 2794300
    [No Abstract]   [Full Text] [Related]  

  • 28. Subcutaneous immunoglobulin: facilitated infusion and advances in administration.
    Wasserman RL
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):75-7. PubMed ID: 25546770
    [No Abstract]   [Full Text] [Related]  

  • 29. Absence of seroconversion following treatment with hepatitis B immune globulin containing antibody to human immunodeficiency virus.
    Phillips M; Cummins LM
    Hepatology; 1988; 8(3):497-8. PubMed ID: 3371869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of immune globulin preparations.
    CMAJ; 1988 Sep; 139(6):522. PubMed ID: 3165687
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans.
    Pollack M
    J Infect Dis; 1983 Jun; 147(6):1090-8. PubMed ID: 6406615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Other uses of gamma globulins and their evaluation].
    Girón Caro F
    An Esp Pediatr; 1989 Sep; 31 Suppl 38():113-5. PubMed ID: 2484995
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of immunoglobulin preparations for intravenous use.
    Barandun S; Isliker H
    Vox Sang; 1986; 51(2):157-60. PubMed ID: 3535252
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety of immune globulins in relation to HTLV-III.
    FDA Drug Bull; 1986 Jun; 16(1):3. PubMed ID: 3015704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative immune globulin preparation when standard immune serum globulin is not available.
    Lutwick LI; Wu EH
    JAMA; 1991 Mar; 265(9):1114. PubMed ID: 1995995
    [No Abstract]   [Full Text] [Related]  

  • 36. [Do immunoglobulins have a value and a future in the treatment of severe bacterial infections?].
    Baumgartner JD
    Presse Med; 1990 Feb; 19(5):196-8. PubMed ID: 2137913
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA: Thrombosis risk with immune globulin products.
    Mitka M
    JAMA; 2013 Jul; 310(3):247. PubMed ID: 23860971
    [No Abstract]   [Full Text] [Related]  

  • 38. Passive immunization against tetanus with human immune globulin.
    RUBBO SD; SURI JC
    Br Med J; 1962 Jul; 2(5297):79-81. PubMed ID: 14494846
    [No Abstract]   [Full Text] [Related]  

  • 39. Passive transfer of immunity in human schistosomiasis mansoni: attempt to prevent infection by repeated injections of hyperimmune antischistosome gamma globulin.
    Cook JA; Warren KS; Jordan P
    Trans R Soc Trop Med Hyg; 1972; 66(5):777-80. PubMed ID: 4119142
    [No Abstract]   [Full Text] [Related]  

  • 40. Selecting a polyclonal immune globulin treatment for a patient with primary immune deficiency disease: Role of the clinical pharmacist.
    Tichy EM; Vaughan L
    Am J Health Syst Pharm; 2016 Apr; 73(8):533-46. PubMed ID: 27045066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.